JAN (NYSE:JAN) Stock Now Rated “Moderate Buy” by Wall Street Analysts

Shares of JAN (NYSE:JAN) have been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $32.44.

JAN has been the subject of several recent analyst reports. Wall Street Zen upgraded JAN from a “sell” rating to a “hold” rating in a research note on Saturday, August 8th. Barclays boosted their price objective on JAN from $33.00 to $34.00 and gave the company an “overweight” rating in a report on Monday, August 31st. Huntington began coverage on shares of JAN in a report on Thursday, September 10th. They set an “outperform” rating and a $36.00 target price on the stock. Zacks Research cut JAN from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, Scotiabank increased their price objective on shares of JAN from $31.00 to $33.00 and gave the stock a “sector outperform” rating in a report on Thursday, September 17th.

Institutional Investors Weigh In On JAN

A number of hedge funds have recently made changes to their positions in the business. WINTON GROUP Ltd acquired a new position in shares of JAN during the second quarter worth approximately $2,985,000. Engineers Gate Manager LP acquired a new stake in JAN in the 2nd quarter valued at approximately $15,274,000. Greenland Capital Management LP acquired a new stake in JAN in the 2nd quarter valued at approximately $575,000. Readystate Asset Management LP acquired a new stake in JAN in the 2nd quarter valued at approximately $1,724,000. Finally, Wellington Management Group LLP bought a new stake in JAN during the 2nd quarter valued at $8,739,000. Institutional investors own 6.27% of the company’s stock.

JAN Stock Performance

Shares of JAN stock opened at $28.74 on Tuesday. The firm has a fifty day simple moving average of $30.14 and a 200-day simple moving average of $28.00. JAN has a twelve month low of $22.76 and a twelve month high of $32.83.

JAN (NYSE:JAN) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.18). The company had revenue of $216.46 million for the quarter, compared to analysts’ expectations of $203.32 million. The company’s quarterly revenue was up 45.4% on a year-over-year basis. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. As a group, equities analysts predict that JAN will post 0.97 earnings per share for the current fiscal year.

JAN Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Friday, December 18th will be given a $0.0475 dividend. The ex-dividend date is Friday, December 18th. This represents a $0.57 annualized dividend and a yield of 2.0%.

About JAN

JanOne Inc (NYSE: JAN) is a publicly traded company focused on addressing the opioid crisis through the development and commercialization of solutions intended to improve the treatment and prevention of opioid use disorder. The company has described its mission as combining business, technology and scientific initiatives to help reduce opioid-related harm.

JanOne’s activities have included biotechnology and pharmaceutical-development initiatives, as well as investments in technologies and businesses connected with healthcare and financial services.